KD Logo

Clover Health Investments Corp [CLOV] Investment Appeal on the Rise

Clover Health Investments Corp’s filing revealed that its Director Loengard Anna U acquired Company’s shares for reported $0.1 million on Mar 14 ’24. In the deal valued at $0.73 per share,137,000 shares were bought. As a result of this transaction, Loengard Anna U now holds 538,841 shares worth roughly $0.36 million.

Then, Loengard Anna U bought 13,625 shares, generating $9,946 in total proceeds. Upon buying the shares at $0.73, the Director now owns 15,125 shares.

Before that, Loengard Anna U bought 11,000 shares. Clover Health Investments Corp shares valued at $14,300 were divested by the Director at a price of $1.30 per share. As a result of the transaction, Loengard Anna U now holds 10,000 shares, worth roughly $6700.0.

Cowen upgraded its Clover Health Investments Corp [CLOV] rating to a Market perform from a an Underperform in a research note published on February 02, 2022; the price target was decreased to $3 from $7. A number of analysts have revised their coverage, including Canaccord Genuity’s analysts, who began to cover the stock in early February with a ‘”a Buy”‘ rating. SVB Leerink began covering CLOV with “Mkt perform” recommendation on January 19, 2022.

Price Performance Review of CLOV

On Friday, Clover Health Investments Corp [NASDAQ:CLOV] saw its stock fall -5.88% to $0.67. Over the last five days, the stock has lost -7.76%. Clover Health Investments Corp shares have fallen nearly -29.62% since the year began. Nevertheless, the stocks have fallen -16.89% over the past one year. While a 52-week high of $1.63 was reached on 02/09/24, a 52-week low of $0.71 was recorded on 04/12/24. SMA at 50 days reached $0.8510, while 200 days put it at $1.0114. A total of 11.31 million shares were traded, compared to the trading of 4.71 million shares in the previous session.

Levels Of Support And Resistance For CLOV Stock

The 24-hour chart illustrates a support level at 0.6468, which if violated will result in even more drops to 0.6236. On the upside, there is a resistance level at 0.7066. A further resistance level may holdings at 0.7432. The Relative Strength Index (RSI) on the 14-day chart is 30.71, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0449, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 94.11%. Stochastics %K at 5.08% indicates the stock is a buying.

Most Popular

[the_ad id="945"]